These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 32945239)
1. Development and Validation of a Prognostic Nomogram Based on Residual Tumor in Patients With Nondisseminated Nasopharyngeal Carcinoma. Liao PY; Dong ZY; Huang CT; Tang XR; Liu GD; Zhu-Liu ; Wu DH Technol Cancer Res Treat; 2020; 19():1533033820957035. PubMed ID: 32945239 [TBL] [Abstract][Full Text] [Related]
2. Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases. Lin C; Sun XS; Liu SL; Li XY; Lu N; Li XL; Tang LQ; Guo L Cancer Res Treat; 2020 Jul; 52(3):855-866. PubMed ID: 32164051 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165 [TBL] [Abstract][Full Text] [Related]
4. Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma. Tang LQ; Li CF; Li J; Chen WH; Chen QY; Yuan LX; Lai XP; He Y; Xu YX; Hu DP; Wen SH; Peng YT; Zhang L; Guo SS; Liu LT; Guo L; Wu YS; Luo DH; Huang PY; Mo HY; Xiang YQ; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Cao KJ; Qian CN; Guo X; Zeng YX; Mai HQ; Zeng MS J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26467665 [TBL] [Abstract][Full Text] [Related]
5. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy. Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185 [TBL] [Abstract][Full Text] [Related]
6. Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma. Zhang LL; Huang MY; Li Y; Liang JH; Gao TS; Deng B; Yao JJ; Lin L; Chen FP; Huang XD; Kou J; Li CF; Xie CM; Lu Y; Sun Y EBioMedicine; 2019 Apr; 42():270-280. PubMed ID: 30928358 [TBL] [Abstract][Full Text] [Related]
7. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis. Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182 [TBL] [Abstract][Full Text] [Related]
8. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma. Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119 [TBL] [Abstract][Full Text] [Related]
9. Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma. Lin DF; Li HL; Liu T; Lv XF; Xie CM; Ou XM; Guan J; Zhang Y; Yan WB; He ML; Mao MY; Zhao X; Zhong LZ; Chen WH; Chen QY; Mai HQ; Peng RJ; Tian J; Tang LQ; Dong D J Natl Cancer Inst; 2024 Aug; 116(8):1294-1302. PubMed ID: 38637942 [TBL] [Abstract][Full Text] [Related]
10. Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area. Yao JJ; Lin L; Gao TS; Zhang WJ; Lawrence WR; Ma J; Sun Y Cancer Res Treat; 2021 Jul; 53(3):657-670. PubMed ID: 33285052 [TBL] [Abstract][Full Text] [Related]
11. A nomogram based on circulating CD8 Yan C; Yang G; Zhang C; Chen K; Sun Y; Liang Z; Lai L; Li L; Qu S; Zhu XD Radiat Oncol; 2024 Aug; 19(1):108. PubMed ID: 39138513 [TBL] [Abstract][Full Text] [Related]
12. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort. Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment. Liang W; Shen G; Zhang Y; Chen G; Wu X; Li Y; Li A; Kang S; Yuan X; Hou X; Huang P; Huang Y; Zhao H; Tian Y; Zhao C; Zhang L Chin J Cancer; 2016 Nov; 35(1):98. PubMed ID: 27887636 [TBL] [Abstract][Full Text] [Related]
14. Regional lymph node density-based nomogram predicts prognosis in nasopharyngeal carcinoma patients without distant metastases. Ma J; Zhao R; Wu YL; Liu Y; Jin GQ; Su DK Cancer Imaging; 2023 Dec; 23(1):123. PubMed ID: 38102725 [TBL] [Abstract][Full Text] [Related]
15. The prognostic value of pretreatment Gu LW; Zhang X; Zhang J; Xiao BB; Wu LP; Tang LQ; Guo L; Liu LT Oral Oncol; 2024 Sep; 156():106928. PubMed ID: 38968724 [TBL] [Abstract][Full Text] [Related]
16. A novel nomogram to predict survival in patients with recurrent nasopharyngeal carcinoma after salvage endoscopic surgery. Li W; Lu H; Liu J; Liu Q; Wang H; Zhang H; Hu L; Zhao W; Gu Y; Li H; Sun X; Wang D Oral Oncol; 2020 Dec; 111():104922. PubMed ID: 32712576 [TBL] [Abstract][Full Text] [Related]
17. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers. Lai C; Zhang C; Lv H; Huang H; Ke X; Zhou C; Chen H; Chen S; Zhou L Cancer Med; 2021 Jun; 10(11):3511-3523. PubMed ID: 33973727 [TBL] [Abstract][Full Text] [Related]
18. Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma. Mi JL; Xu M; Liu C; Wang RS Medicine (Baltimore); 2021 Nov; 100(47):e27947. PubMed ID: 34964774 [TBL] [Abstract][Full Text] [Related]
19. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma. Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054 [TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: A study based on a phase III randomized clinical trial with 10-year follow-up. Sun XS; Li XY; Xiao BB; Liu SL; Chen QY; Tang LQ; Mai HQ Oral Oncol; 2020 Jan; 100():104490. PubMed ID: 31790913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]